These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4114486)

  • 1. Phase II study of bleomycin (NSC-125066) therapy for large bowel cancer.
    Moertel CG; Arena PJ; Schutt AJ; Reitemeir RJ; Hahn RG
    Cancer Chemother Rep; 1972 Apr; 56(2):207-10. PubMed ID: 4114486
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleomycin (NSC-125066): phase I clinical study.
    Sonntag RW
    Cancer Chemother Rep; 1972 Apr; 56(2):197-205. PubMed ID: 4114485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with bleomycin treatment of 551 cases of mouth carcinoma in Japan].
    Ueno T; Shimizu M; Michi K; Ishibashi K; Kohama G
    Bull Tokyo Med Dent Univ; 1973 Jun; 20(2):193-201. PubMed ID: 4125241
    [No Abstract]   [Full Text] [Related]  

  • 4. A clinical review of bleomycin--a new antineoplastic agent.
    Blum RH; Carter SK; Agre K
    Cancer; 1973 Apr; 31(4):903-14. PubMed ID: 4122362
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of combination therapy with bleomycin (NSC-125066) and dibromodulcitol (NSC-104800) on squamous cell carcinoma in man.
    Onuma T; Holland JF; Sako K; Shedd DP
    Cancer Chemother Rep; 1972 Oct; 56(5):625-33. PubMed ID: 4119907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Assessment of a year's systematic use in cancer of the otorhinolaryngological area of a new antimitotic: bleomycin. Study of 209 patients].
    Laccourreye H; De Saint Macary M; Narcy P; Trotoux J; Marsan C; Haguet JF; Soudant J
    Ann Otolaryngol Chir Cervicofac; 1972; 89(4):219-28. PubMed ID: 4116541
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleomycin (NSC-125066) therapy of responsive solid tumors.
    Durkin WJ; Pugh RP; Jacobs E; Sadoff L; Pajak T; Bateman JR
    Oncology; 1976; 33(5-6):260-4. PubMed ID: 68454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of bleomycin in patients with incurable carcinoma of the oral cavity].
    Fries R; Wilfert KH
    Osterr Z Erforsch Bekampf Krebskr; 1973; 28(1):29-32. PubMed ID: 4123658
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037).
    Sonntag RW; Brunner KW; Batz K; Ryssel HJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):429-31. PubMed ID: 50125
    [No Abstract]   [Full Text] [Related]  

  • 10. Intra-arterial bleomycin therapy in inoperable squamous cell carcinomas.
    Huntington MC; DuPriest RW; Fletcher WS
    Cancer; 1973 Jan; 31(1):153-8. PubMed ID: 4118911
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of bleomycin in the treatment of cancer].
    Ichikawa T
    Naika; 1971 Oct; 28(4):672-7. PubMed ID: 4108606
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Reitemeier RJ; Schutt AJ; Hahn RG
    Cancer Chemother Rep; 1971 Jun; 55(3):303-7. PubMed ID: 5115851
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical trial of intravenous and intracavitary bleomycin.
    Cunningham TJ; Olson KB; Horton J; Wright A; Hussain M; Davies JN; Harrington G
    Cancer; 1972 May; 29(5):1413-9. PubMed ID: 4112172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anatomo- and cyto-pathological aspects of laryngeal cancers treated with bleomycin].
    Marsan C; Trotoux J; Narcy P; de Saint-Macary M
    Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):185-201. PubMed ID: 4123907
    [No Abstract]   [Full Text] [Related]  

  • 15. Bleomycin: a clinical evaluation of the agent on its own or in combination with mitomycin C.
    van Dyk JJ; Falkson G; Falkson HC
    S Afr Med J; 1972 Dec; 46(49):1921-6. PubMed ID: 4120162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of Bleomycin in tumor pateints].
    Rieche K; Matthias M
    Arch Geschwulstforsch; 1973; 41(3):232-40. PubMed ID: 4126058
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary evaluation of bleomycin in feline and canine squamous cell carcinoma.
    Buhles WC; Theilen GH
    Am J Vet Res; 1973 Feb; 34(2):289-91. PubMed ID: 4119568
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Raney M; Logan T
    Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.
    Livingston RB; Bodey GP; Gottlieb JA; Frei E
    Cancer Chemother Rep; 1973 Apr; 57(2):219-24. PubMed ID: 4126382
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma.
    Johnson DE; Chalbaud RA; Holoye PY; Samuels ML
    Cancer Chemother Rep; 1975; 59(2 Pt 1):433-5. PubMed ID: 50126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.